Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer

JAMA Oncol. 2020 Apr 1;6(4):585-586. doi: 10.1001/jamaoncol.2019.6709.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms* / drug therapy
  • Chemotherapy, Adjuvant
  • Humans
  • Neoplasm Recurrence, Local
  • Receptors, Estrogen

Substances

  • Receptors, Estrogen